Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS Framework Agreement for London, Branded Medicines - Tranche A and Annual

NHS England

This public procurement record has 2 releases in its history.

Award

11 Aug 2022 at 15:08

Award Notice
Tender

08 Mar 2022 at 11:40

Tender Notice
Summary of the contracting process

The National Health Service (NHS) England has awarded a contract for a Framework Agreement for London, Branded Medicines. The procurement process was initiated through a tender with the reference number CM/PHR/20/5614. The framework covers two lots: Tranche A and Annual Tranche, with respective periods from September 2022 to August 2024 and September 2022 to August 2023. The NHS England as the buyer has selected multiple suppliers for each lot.

This tender for the NHS Framework Agreement presents significant business opportunities for pharmaceutical companies and suppliers of branded medicines. Businesses in the pharmaceutical products industry, both large-scale and small and medium-sized enterprises, can compete by offering their products or services in response to this procurement. The open procedure procurement method allows fair competition among suppliers, with options for extending the framework agreement, providing a potential pathway for sustained business growth and collaboration.

How relevant is this notice?

Notice Information

Notice Title

NHS Framework Agreement for London, Branded Medicines - Tranche A and Annual

Notice Description

NHS London Branded Medicines - Tranche A <br/><br/>Offer reference number: CM/PHR/20/5614<br/><br/>CM/PHR/20/5614/01 - NHS Framework for LONDON Branded Medicines - Tranche A. Period of framework: 1 September 2022 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months<br/><br/>CM/PHR/20/5614/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

Lot Information

CM/PHR/20/5614/01 - NHS Framework for LONDON Branded Medicines - Tranche A

NHS London Branded Medicines - Tranche A

Offer reference number: CM/PHR/20/5614

CM/PHR/20/5614/01 - NHS Framework for LONDON Branded Medicines - Tranche A. Period of framework: 1 September 2022 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/20/5614/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Additional information: Further to II.2.5 - Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: There will be an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/20/5614/02 - NHS Framework for LONDON Branded Medicines - Annual Tranche

NHS London Branded Medicines - Tranche A

Offer reference number: CM/PHR/20/5614

CM/PHR/20/5614/01 - NHS Framework for LONDON Branded Medicines - Tranche A. Period of framework: 1 September 2022 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/20/5614/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Additional information: Further to II.2.5 - Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: There will be an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-031f20
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/022184-2022
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£276,524,326 £100M-£1B
Lots Value
£276,524,326 £100M-£1B
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
11 Aug 20224 years ago
Submission Deadline
12 Apr 2022Expired
Future Notice Date
Not specified
Award Date
15 Jul 20224 years ago
Contract Period
1 Sep 2022 - 31 Aug 2023 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Additional Buyers

The NHS Commissioning Board (operating under the name of NHS England)

Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS2 7UE
Postcode Area
Leeds
Country
England
Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified
Local Authority
Leeds
Electoral Ward
Little London & Woodhouse
Westminster Constituency
Leeds Central and Headingley

Supplier Information

Number of Suppliers
28
Supplier Names

Abbvie Ltd

Accord-UK Ltd

Almirall

Amgen Ltd

AstraZeneca

Aventis Pharma ltd t/a Sanofi

Celltrion Healthcare United Kingdom Limited

Eli Lilly and Company Ltd

Gedeon Richter UK Ltd

GlaxoSmithKline UK Limited

Ipsen

Janssen-Cilag Ltd

Merck Serono Limited

Merck Sharpe and Dohme (UK) Limited

Merz

Novo Nordisk

Organon Pharmaceuticals UK Ltd

Pfizer Ltd

Pharmacosmos UK Ltd

Roche Products Ltd

Sandoz Ltd

Sobi (Swedish Orphan Biovitrum Ltd)

Takeda UK Ltd

Teva UK Limited

Thornton and Ross Ltd

UCB Pharma Ltd (primary)

Vifor Pharma UK Ltd

Zentiva Pharma UK Ltd

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...